Elite Pharmaceuticals (ELTP) Consolidated Net Income (2010 - 2026)
Elite Pharmaceuticals (ELTP) recorded Consolidated Net Income of $5.91 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$5.88 million a year earlier and down 68.0% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Consolidated Net Income (2010 - 2026) Analysis & Trends
On a TTM basis, Elite Pharmaceuticals' Consolidated Net Income came in at $56.67 million as of Jun 30, 2026; for FY2026 (ended Mar 31, 2026), it came in at $44.87 million.
- Annual Consolidated Net Income has a five-year compound annual growth rate of 61.0% (FY2021 to FY2026).
- Across earlier fiscal years, Consolidated Net Income came in at -$4.4 million in FY2025, $20.15 million in FY2024 (+465.6%), $3.56 million in FY2023 (-55.7%) and $8.04 million in FY2022 (+94.0%).
- Quarterly Consolidated Net Income has ranged from -$11.04 million in fiscal Q2 2025 to $18.59 million in fiscal Q3 2026 over the past five years.
- Peak year-over-year performance for Consolidated Net Income in the last five years was growth of 885.7% in fiscal Q2 2024, against a decline of 80.1% in fiscal Q1 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $18.46 million (Q4 2026), $18.59 million (Q3 2026) and $13.7 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,139.85 Bn | 1,108.44 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 634.68 Bn | 554.54 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 500.89 Bn | 474.00 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 354.57 Bn | 308.95 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 300.14 Bn | 264.13 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 263.08 Bn | 236.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.91 Bn | 193.31 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 193.96 Bn | 168.15 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 170.07 Bn | 116.71 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Elite Pharmaceuticals | 269.28 Mn | 150.96 Mn | 13.51 Mn | 5.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.91 Mn |
| Mar 31, 2026 | 18.46 Mn |
| Dec 31, 2025 | 18.59 Mn |
| Sep 30, 2025 | 13.70 Mn |
| Jun 30, 2025 | -5.88 Mn |
| Mar 31, 2025 | 16.91 Mn |
| Dec 31, 2024 | -10.89 Mn |
| Sep 30, 2024 | -11.04 Mn |
| Jun 30, 2024 | 615,773.00 |
| Mar 31, 2024 | 3.36 Mn |
| Dec 31, 2023 | 706,354.00 |
| Sep 30, 2023 | 14.93 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | -1.23 Mn |
| Dec 31, 2022 | 2.97 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 305,883.00 |
| Mar 31, 2022 | 2.43 Mn |
| Dec 31, 2021 | 2.28 Mn |
| Sep 30, 2021 | 1.79 Mn |
API Access
Elite Pharmaceuticals Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();